迈克生物(300463.SZ)：上半年净利润3404.25万元 同比下降83.12%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 1.075 billion yuan, representing a year-on-year decrease of 15.94% [1] - The net profit attributable to shareholders was 34.0425 million yuan, down 83.12% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 63.0562 million yuan, reflecting a year-on-year decline of 68.24% [1] - The basic earnings per share were reported at 0.0556 yuan [1]